Total Payments
$7,899
2024 Payments
$989.72
Companies
22
Transactions
123
Medicare Patients
3,202
Medicare Billing
$156,840
Payment Breakdown by Category
Food & Beverage$7,180 (90.9%)
Consulting$500.00 (6.3%)
Research$125.00 (1.6%)
Other$60.00 (0.8%)
Education$33.97 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,180 | 114 | 90.9% |
| Consulting Fee | $500.00 | 2 | 6.3% |
| Unspecified | $125.00 | 1 | 1.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $60.00 | 1 | 0.8% |
| Education | $33.97 | 5 | 0.4% |
Payments by Type
General
$7,774
122 transactions
Research
$125.00
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,988 | 31 | $0 (2024) |
| GlaxoSmithKline, LLC. | $790.40 | 16 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $591.03 | 6 | $0 (2023) |
| Amgen Inc. | $590.53 | 8 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $588.75 | 9 | $0 (2020) |
| Takeda Pharmaceuticals U.S.A., Inc. | $500.00 | 2 | $0 (2018) |
| Lilly USA, LLC | $496.90 | 8 | $0 (2024) |
| Novo Nordisk Inc | $487.86 | 6 | $0 (2024) |
| Amarin Pharma Inc. | $255.69 | 3 | $0 (2019) |
| ABBVIE INC. | $249.35 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $989.72 | 11 | AstraZeneca Pharmaceuticals LP ($254.92) |
| 2023 | $1,203 | 14 | GlaxoSmithKline, LLC. ($248.52) |
| 2022 | $589.13 | 6 | Novo Nordisk Inc ($227.06) |
| 2021 | $389.46 | 4 | AstraZeneca Pharmaceuticals LP ($250.00) |
| 2020 | $614.14 | 6 | AstraZeneca Pharmaceuticals LP ($313.62) |
| 2019 | $928.50 | 10 | Amarin Pharma Inc. ($255.69) |
| 2018 | $1,353 | 16 | Amgen Inc. ($334.22) |
| 2017 | $1,833 | 56 | AstraZeneca Pharmaceuticals LP ($595.30) |
All Payment Transactions
123 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/06/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $112.00 | General |
| 11/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: RESPIRATORY | ||||||
| 08/29/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $27.53 | General |
| Category: Diabetes Care | ||||||
| 07/31/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $6.26 | General |
| Category: RESPIRATORY | ||||||
| 05/29/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Education | In-kind items and services | $11.56 | General |
| Category: Respiratory | ||||||
| 05/21/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $115.65 | General |
| Category: Diabetes | ||||||
| 05/09/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Respiratory | ||||||
| 05/07/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $112.00 | General |
| Category: VACCINES | ||||||
| 02/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $118.36 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/31/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $111.37 | General |
| Category: Diabetes | ||||||
| 11/07/2023 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $10.84 | General |
| Category: Diabetes Care | ||||||
| 10/12/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $111.13 | General |
| Category: Diabetes | ||||||
| 10/05/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $87.11 | General |
| Category: KRYSTEXXA | ||||||
| 08/16/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $113.00 | General |
| Category: RESPIRATORY | ||||||
| 07/20/2023 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $151.12 | General |
| Category: Neuromodulation | ||||||
| 05/26/2023 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $1.53 | General |
| Category: Diabetes Care | ||||||
| 05/18/2023 | AbbVie Inc. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $124.35 | General |
| Category: NEUROSCIENCE | ||||||
| 05/15/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: VACCINES | ||||||
| 05/03/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $104.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/03/2023 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: Diabetes Care | ||||||
| 04/06/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $102.24 | General |
| Category: Diabetes | ||||||
| 03/16/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $116.84 | General |
| Category: DIABETES | ||||||
| 03/01/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $117.00 | General |
| Category: VACCINES | ||||||
| 01/19/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $124.00 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 610 | 629 | $130,631 | $19,209 |
| 2022 | 10 | 678 | 696 | $135,873 | $17,946 |
| 2021 | 12 | 904 | 968 | $231,620 | $60,526 |
| 2020 | 17 | 1,010 | 1,120 | $221,039 | $59,159 |
Total Patients
3,202
Total Services
3,413
Medicare Billing
$156,840
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 110 | 110 | $42,224 | $4,765 | 11.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 11 | 11 | $9,363 | $3,088 | 33.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 60 | 71 | $27,042 | $2,874 | 10.6% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 121 | 121 | $6,621 | $2,188 | 33.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 108 | 108 | $5,910 | $1,953 | 33.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 24 | 24 | $5,036 | $1,709 | 33.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 107 | 114 | $30,696 | $1,264 | 4.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 30 | 30 | $2,548 | $907.20 | 35.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 11 | 11 | $781.26 | $332.64 | 42.6% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 13 | 13 | $234.00 | $73.58 | 31.4% |
| 81002 | Urinalysis, manual test | Office | 2023 | 15 | 16 | $176.00 | $54.56 | 31.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 127 | 127 | $49,748 | $5,835 | 11.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 70 | 81 | $31,093 | $2,844 | 9.1% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 133 | 133 | $7,444 | $2,373 | 31.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 30 | 30 | $5,874 | $2,050 | 34.9% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 109 | 109 | $5,991 | $1,960 | 32.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 112 | 119 | $32,479 | $1,281 | 3.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 36 | 36 | $1,898 | $1,034 | 54.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 12 | 12 | $632.52 | $345.42 | 54.6% |
| 82043 | Urine microalbumin (protein) level | Office | 2022 | 25 | 25 | $450.00 | $141.68 | 31.5% |
| 81002 | Urinalysis, manual test | Office | 2022 | 24 | 24 | $264.00 | $81.92 | 31.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 190 | 190 | $75,156 | $25,325 | 33.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 203 | 252 | $68,908 | $13,412 | 19.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 106 | 121 | $47,128 | $9,487 | 20.1% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 51 | 51 | $9,947 | $3,315 | 33.3% |
About Dr. Rae Ringenberg, MD
Dr. Rae Ringenberg, MD is a Family Medicine healthcare provider based in Apopka, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1477500494.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rae Ringenberg, MD has received a total of $7,899 in payments from pharmaceutical and medical device companies, with $989.72 received in 2024. These payments were reported across 123 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($7,180).
As a Medicare-enrolled provider, Ringenberg has provided services to 3,202 Medicare beneficiaries, totaling 3,413 services with total Medicare billing of $156,840. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Apopka, FL
- Active Since 05/27/2006
- Last Updated 08/19/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1477500494
Products in Payments
- FARXIGA (Drug) $1,303
- Trintellix (Drug) $528.15
- JARDIANCE (Drug) $465.10
- INVOKANA (Drug) $450.14
- MOUNJARO (Drug) $440.39
- Ozempic (Drug) $341.59
- SHINGRIX (Biological) $297.33
- Prolia (Biological) $279.92
- Vascepa (Drug) $255.69
- BREZTRI (Drug) $245.61
- AREXVY (Drug) $237.99
- INFINITY (Device) $151.12
- XARELTO (Drug) $138.61
- SOLIQUA (Drug) $135.10
- Xofluza (Drug) $125.17
- AIRSUPRA (Drug) $125.00
- Kerendia (Drug) $125.00
- VRAYLAR (Drug) $125.00
- BEVESPI AEROSPHERE (Drug) $124.87
- QULIPTA (Drug) $124.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Apopka
Ana Williams, Aprn, APRN
Family Medicine — Payments: $7,258
Family Medicine $7,258
Addam Masri, Md, MD
Family Medicine — Payments: $7,107
Family Medicine $7,107
Dr. Jaime Salcedo Varela, Md, MD
Family Medicine — Payments: $4,873
Family Medicine $4,873
Roberto Perez, Md, MD
Family Medicine — Payments: $4,451
Family Medicine $4,451
Mrs. Nadia Rivera, Md, Mph, MD, MPH
Family Medicine — Payments: $3,590
Family Medicine $3,590
Priamvada Singh, M.d, M.D
Family Medicine — Payments: $3,116
Family Medicine $3,116